# A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy

> **NCT00250263** · PHASE4 · COMPLETED · sponsor: **Bayside Health** · enrollment: 30 (actual)

## Conditions studied

- Allergic Rhinitis
- Asthma

## Interventions

- **DRUG:** (agent for immunotherapy) Staloral
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00250263
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250263, "A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00250263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*